Cite
Identification of plasma SAA2 as a candidate biomarker for the detection and surveillance of non-small cell lung cancer.
MLA
Zhang, Fa-Fu, et al. “Identification of Plasma SAA2 as a Candidate Biomarker for the Detection and Surveillance of Non-Small Cell Lung Cancer.” Neoplasma, vol. 68, no. 6, Nov. 2021, pp. 1301–09. EBSCOhost, https://doi.org/10.4149/neo_2021_210228N263.
APA
Zhang, F.-F., Han, B., Xu, R.-H., Zhu, Q.-Q., Wu, Q.-Q., Wei, H.-M., Cui, Z.-L., Zhang, S.-L., & Meng, M.-J. (2021). Identification of plasma SAA2 as a candidate biomarker for the detection and surveillance of non-small cell lung cancer. Neoplasma, 68(6), 1301–1309. https://doi.org/10.4149/neo_2021_210228N263
Chicago
Zhang, Fa-Fu, Bin Han, Run-Hao Xu, Qing-Qing Zhu, Qi-Qi Wu, Hui-Min Wei, Zhi-Lei Cui, Shu-Lin Zhang, and Min-Jie Meng. 2021. “Identification of Plasma SAA2 as a Candidate Biomarker for the Detection and Surveillance of Non-Small Cell Lung Cancer.” Neoplasma 68 (6): 1301–9. doi:10.4149/neo_2021_210228N263.